行业研究报告

PitchBook-2025年二季度卫生技术公共报表和评估指南(英)-2025

2025-07资本市场10PitchBook

EMERGING TECH RESEARCH PitchBook Data, Inc. Nizar Tarhuni Executive Vice President of Research

报告摘要

EMERGING TECH RESEARCH PitchBook Data, Inc. Nizar Tarhuni Executive Vice President of Research

报告信息

文件全名
《PitchBook-2025年二季度卫生技术公共报表和评估指南(英)-2025-10页.pdf》
适合读者
投资人行业研究员
核心数据
  1. MultiPlan), up 248% YTD, to Veradigm, down 48% YTD. Telehealth platform Hims & Hers continued its volatile 2025. In Q2, prices
  2. GLP-1s at a discount. However, shares dropped 30% when Novo abruptly called off the deal. Despite this setback, Hims ended the
  3. quarter up 98% YTD.
  4. • Subsector highlights: Whereas the S&P 500 and NASDAQ delivered 10% returns over the last 90 days, the virtual care & remote
  5. patient monitoring (RPM) segment outperformed with a median return of 19%. The sector was led by strong gains for Modivcare
核心议题
IPO

常见问题

《PitchBook-2025年二季度卫生技术公共报表和评估指南(英)-2025》主要包含哪些内容?

EMERGING TECH RESEARCH PitchBook Data, Inc. Nizar Tarhuni Executive Vice President of Research核心数据:MultiPlan), up 248% YTD, to Veradigm, down 48% YTD. Telehealth platform Hims & Hers continued its volatile 2025. In Q2, prices;GLP-1s at a discount. However, shares dropped 30% when Novo abruptly called off the deal. Despite this setback, Hims ended the;quarter up 98% YTD.。

这份报告由哪家机构发布?

本报告由PitchBook发布,发布于 2025 年。

这份报告覆盖哪一年、篇幅多大?

覆盖 2025 年,全文约 10。

这份报告是免费的吗?如何获取?

本报告免费查阅,登录资料宝后即可在线获取完整内容。

这份报告适合哪些读者?

适合投资人、行业研究员等读者参考。

报告涉及哪些关键议题?

重点分析了IPO等议题。

继续阅读

同分类报告

查看全部 →
📱 登录